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Abstract Grape pomace, a winemaking industry by-product,
is a rich source of bioactive dietary compounds. Using prote-
ases we have developed an enzymatic process for obtaining a
water-soluble extract (GP-EE) that contains biomolecules
such as peptides, carbohydrates, lipids and polyphenols in
soluble form. Of especial interest is its high polyphenol con-
tent (12 %), of which 77 % are flavonoids and 33 % are
phenolic acids. The present study evaluates in vitro the poten-
tial anti-inflammatory effect of GP-EE by monitoring the
expression of inflammatory molecules on N13 microglia cells
stimulated with lipopolysaccharide (LPS). GP-EE decreases
the mRNA levels of the inflammatory molecules studied. The
molecules under study were as follows: inducible nitric oxide
synthase (iNOS), tumor necrosis factor- α (TNF-α),
interleukin-1β (IL-1β), the ionized calcium binding adaptor
molecule-1(Iba-1) and the Toll like receptor-4 (TLR-4), as
well as the iNOS protein level in LPS-stimulated microglia.
Our findings suggest that, as a result of its ability to regulate
excessive microglial activation, GP-EE possesses anti-
inflammatory properties. Therefore, acting as a chemopreven-
tive agent, it may be of therapeutic interest in neurodegener-
ative diseases involving neuroinflammation. We can,
therefore, propose GP-EE as a useful natural extract and one
that would be beneficial to apply in the field of functional
foods.
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Abbreviations
GP Grape pomace
GP-EE Grape pomace enzymatic extract
LPS Lipopolysaccharide
iNOS Inducible nitric oxide synthase
TNF-α Tumor necrosis factor- alpha
IL-1β Interleukin-1β
TLR-4 Toll like receptor-4
Iba-1 Ionized calcium binding adaptor molecule-1
UPLC Ultra-high performance liquid chromatography
RT Reverse transcription
Introduction
Grape pomace, a winemaking industry by-product, has tradi-
tionally been considered as an environmental problem.
However, GP is being increasingly recognized as a source of
bioactive dietary compounds such as polyphenols [1]. To date,
its efficient recovery to convert it into a high value-added
product has been accomplished by conventional solid–liquid
extraction with organic solvents (ethanol, methanol, ethyl
ether, ethyl acetate, etc.) or by heated sulphurated water.
It is also recovered enzymatically with carbohydrate
hydrolases (cellulase and pectinase [1–5] and by physi-
cal methods such as superheated liquid extraction and
supercritical fluid extraction.
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Grape polyphenols possess many biological activities, in-
cluding anti-inflammatory properties [6] that can be beneficial
to human health. It is now widely accepted that inflammation
plays a pivotal role in neurodegenerative processes like
Parkinson’s disease or Alzheimer’s disease. The hallmark of
neuroinflammation is the activation of microglia, the brain’s
major defense against immune challenge. However, activated
microglia may also contribute to neurodegeneration through
the release of pro-inflammatory and/or cytotoxic factors such
as IL-1 β, TNF- α, nitric oxide (NO) and reactive oxygen
intermediates, among others. It can therefore be assumed that
a certain degree of brain inflammation is required to repair the
damaged tissue yet excessive inflammation causes neuronal
cell death. It would be interesting, therefore, to search for
molecules that could help control inflammation in the CNS
[7–10]. Natural polyphenols have been shown to exert neuro-
protective properties by inhibiting the release of pro-
inflammatory cytokines after LPS-activation of microglia
[11–14].
This paper describes a new extraction method based on
enzymatic technology for obtaining a valuable product from
GP. The chemical and functional characterization of the enzy-
matic extract GP-EE, focusing on its anti-inflammatory prop-
erties, is also described.
Materials and Methods
Enzymatic Hydrolysis
GP was resuspended in water at a 20 % concentration.
Enzymatic hydrolysis was performed using an endoprotease
mixture (0,3 %v/v) in a bioreactor using the pH-stat method at
60 °C and pH 8. The solids were then removed by filtration
and the final product (GP-EE) was concentrated using a rotary
evaporator, obtaining a completely water-soluble syrup. The
concentrated extract was lyophilized to obtain a fine red
powder with a phenolic yield of 12 % of dry matter.
GP-EE Chemical Composition
The chemical composition of GP-EE, as protein, fat, carbo-
hydrates and fiber, was characterized by using AOAC stan-
dard protocols [15]. Molecular-mass protein distribution in
GP-EE was determined by size-exclusion chromatography
using an ÄKTA-purifier (GE Healthcare) according to
the procedure described by Bautista [16], using a
Superdex PeptideTM 10/300 GL column (optimum sep-
aration range 0.1–7 kDa). Total phenolics were deter-
mined using a modification of the Folin-Ciocalteau
method [17].
Phenolic Composition by UPLC
The analysis of the individual phenolics was undertaken via
ultra-high performance liquid chromatography (UPLC) using
Agilent 1260 system equipment with a diode-array detector.
Phenols were separated on a C18 Poroshell 120 column
(2.7 μm particle size, 5 cm×4.6 mm) (Agilent, Palo Alto,
CA) and maintained at 25 °C. The solvents used were water-
formic acid (99:1, v/v) as solvent A, and acetonitrile as solvent
B. The flow rate was 1.5 mL/min and the injection volume
was 30 μl. The linear gradient elution was: 0 min, 100 % A;
5 min, 95 % A and 5 % B; 20 min, 50 % A and 50 % B;
22 min, 100 % A; 25 min, 100 % A. The detection wave-
lengths were 280 nm (flavanols and benzoic acids); 320 nm
(cinnamic acids and their derivates) and 370 nm (flavonols).
The analyses were performed in triplicate for each sample.
Individual phenols were identified by comparing their re-
tention time and spectra against standards. The external cali-
bration method was used for quantification comparing the
areas with standards of gallic, protocatechuic, caffeic acid,
catechin, epicatechin, quercetin-3-O- glucoside and
kaempferol-3-O-glucoside. All standards were HPLC-grade
and purchased from Sigma-Aldrich (Madrid, Spain).
Phenolic compounds which were not available as standards
were identified by their retention time and spectra, according
to the literature. These compounds have been assayed by
assuming that their molar absorptivity is the same as that of
the corresponding free standard molecule.
N13 Cell Culture and Immunostimulation Assays
After stimulation with LPS, N13 microglia produces a reper-
toire of cytokines similar to primarymicroglia [18]. Cells were
grown in RPMI 1640 (PAA, Linz, Austria) supplementedwith
2 mM glutamine (PAA), 5 % (v/v) fetal bovine serum (PAA),
100 U/mL 131 penicillin, and 100 μg/mL streptomycin (PAA)
at 37 °C and 5 % CO2. For subculture, cells were removed
from the culture flask with a scraper, resuspended in the
culture medium, and subcultured in 6-well plates for experi-
ments (Nunc, Thermo Fisher Scientific, USA) in culture me-
dium at a density of 5.0×105 cells/well/2 mL. After adhering,
cells were stimulated with LPS (0.01 μg/mL) and simulta-
neously different concentrations of GP-EE were added (0, 1, 5
and 10 μg/mL of polyphenols). Finally, they were collected at
different times after stimulation (1, 4 and 6 h), to extract RNA
and proteins. Cells treated only with cell culture media but no
GP-EE or LPS were used as control.
Determination of Cell Viability
After 24 h of GP-EE treatment (0, 1, 5 and 10 μg/mL of
polyphenols), cells were washed with 1 mL of PBS and
stained for 60 min with 1 mL of a 1 % crystal violet solution.
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After careful aspiration of the crystal violet solution, the plates
were washed with deionized water and dried prior to the
solubilization of the bound dye with 1 mL of a 1 % aqueous
SDS solution. The optical density of the plates was measured
at 590 nm in a microplate spectrophotometer.
RNA Extraction and Reverse Transcription
For PCR analysis, total RNA was extracted from collected
cells using the TripureTM Isolation Reagent (Roche,
Germany), following the manufacturer’s instructions. This
procedure allows the isolation of total RNA, DNA and protein
fractions from a single sample. Reverse transcription (RT) was
performed using random hexamers primers, 3 μg of total
RNA as a template and the High-Capacity cDNA Archive
Kit (Applied Biosystems) following the manufacturer’s rec-
ommendations as previously described [19].
Real-Time PCR
After RT, the cDNAwas diluted in sterile water and used as
template for amplification by the polymerase chain reaction.
For real time RT-PCR, each specific gene product was ampli-
fied using commercial TaqManTM probes employing the ABI
Prism 7000 sequence detector (Applied Biosystems, Madrid,
Spain) as previously described [18]. The cDNA levels were
determined using GAPDH as housekeeper. Threshold cycle
(Ct) values were calculated using the software supplied by
Applied Biosystems.
Immunoblot
Protein pellets obtained using the TripureTM isolation reagent
were resuspended in 4 % SDS and 8 M urea in 40 mM Tris–
HCl. The total recovery and integrity of these fractions were
determined by Lowry et al. [20] and SDS-polyacrylamide gel
electrophoresis. Immunoblots were performed [21].
Membranes were incubated overnight at 4 °C with the rabbit
polyclonal antibody antiinOS (BD Bioscience, USA, 1/1000)
or the mouse monoclonal antibody against β-actin (Sigma-
Aldrich) at a dilution of 1/10,000. The blots were developed
using the ECL-plus detection method (Amersham).
For quantification, the optical density of the individual
bands was analysed using PCBAS 2.08 software (Raytest
Inc, Berlin, Germany) and the optical density of each band
was normalized relative to the optical density of β-actin.
Statistics
Data were expressed individually, as mean±SD or as a per-
centage with respect to control.
At least three independent experiments were conducted
and analyzed statistically using t-student Bonferroni or analy-
sis. Different levels of significance (*p<0.05 and **p<0.001)
are considered statistically significant.
Results and Discussion
Obtaining the Grape Pomace Enzymatic Extract (GP-EE)
GP is a water-insoluble solid by-product composed mainly of
fiber (54 %) and minor components such as fat (7 %), proteins
(9 %) and soluble carbohydrates (14 %). We have developed a
new process using proteases in order to extract and solubilize
valuable compounds such as peptides, polyphenols, etc. In
this process, the strategy consisted of breaking down cell
structure, thus solubilizing the protein. This led to the release
of molecules such as phenolics or peptides. Enzymatic extrac-
tion processes using carbohydrate hydrolase (cellulase and
pectinase) enzymes have been described previously [2, 22],
but not the use of proteases. Therefore not only have we tried
to recover phenolics but also other functional biomolecules
with anti-inflammatory and antioxidant capacities such as
peptides. The other enzymatic processes hydrolyzed structural
carbohydrates, focusing mainly on the recovery of phenols.
Due to the fact that the stability of the active ingredients is
enhanced at low temperatures and pressures, the biological
extraction process employing hydrolytic enzymes has certain
advantages over classical chemical extraction processes. The
enzymatic extraction method excludes the use of xenobiotics
or toxic reagents, something that must also be taken into
account, as it is more environmentally friendly.
Due to their fiber compounds (cellulose, hemicellulose,
pectin and lignine) carbohydrates, which are the main com-
ponent in GP-EE (47 %), are not extracted by the enzymatic
treatment and remain insoluble and are separated from GP-EE
by centrifugation. The second main compound in GP-EE is
protein (14%) which is present in a greater amount than in GP.
This is due to the use of proteases which extract, solubilize and
hydrolyse the initial insoluble proteins. The physical proper-
ties of the proteins in GP-EE are somewhat different to those
of GP proteins, as shown in Fig. 1. In GP-EE, the proteins are
mainly in the form of peptides and free amino acids. This
change in the protein size modifies drastically water solubility,
thus the components of GP-EE are completely soluble, inde-
pendent of the pH. This results in an increase in nutritional
functionality. Phenols (12%), that have been concentrated due
to the enzymatic process, are the third component. Although
the amount of polyphenols in the GP-EE is similar to that
found by other studies [2], our target was not only to obtain a
phenolic extract but also one that contains polyphenols and
other bioactive molecules such as peptides, carbohydrates and
lipids in a soluble form.
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Finally, the fat content is greatly reduced but it is solubi-
lized due to protein interactions. A similar process of lipid
extraction and solubilization (emulsion) by proteases from a
natural organic matter has also been described [23].
The next goal was to analyze the presence of bioactive
compounds that may be involved in the beneficial activities of
GP-EE. Using bibliographical data, we have devised a series
of bioactive compounds with anti-inflammatory, antitumoral
and antioxidant properties that are present in grape seeds and
skin, such as catechin, epicathechin, gallocatechin,
kaempferol, procyanidin B1, procyanidin B2, quercetin and
resveratrol. Although a similar grape pomace enzymatic ex-
tract has been already characterized [24], we have performed
an in-depth characterization of the polyphenolic and protein
profile of our GP-EE. Interestingly, present results suggest that
the enzymatic extract of grape pomace (GP-EE) comprises a
rich source of bioactive non-colored polyphenols (12 %),
comprising mainly flavonoids (flavanols and flavonols) and
phenolic acids.
Flavonoids are important for human health because of their
high levels of pharmacological activity as radical scavengers
[25]. Three flavanols, six flavonols and four phenolic acids
were identified and quantified by UPLC (Table 1). Among the
flavanols detected, epicatechin and catechin were the most
abundant compounds (35.7 and 33.7 mg/100 g, respectively),
while procyanidin B1 was also present in high amounts
(21.6 mg/100 g). The main flavonols were quercetin 3-O-
glucoside, kaempferol 3-O-glucoside and quercetin 3- O-
rutinoside (50.9, 21.9 and 20.5 mg/100 g, respectively).
Although in lower amounts, three O-glycosides from the
aglycones quercetin and kaempferol were also found in the
enzymatic extract.
With respect to the phenolic acids, both hydroxybenzoic
(gallic and protocatechuic) and hydroxycinammic (caffeic and
caftaric) acids were detected in extracts. Protocatechuic acid
was the most abundant phenolic acid (27.1 mg/100 g), al-
though the other phenolic acids were also detected in consid-
erable quantities.
Therefore, polyphenols, including both hydrophobic and
hidrophylic groups that interact with proteins and
polysacharides on the cell wall, can be released after treatment
with proteases.
Fig. 1 Size-exclusion
chromatography and molecular
weight distribution of GP-EE
Table 1 Detailed phenolic
composition and total phenolic
content of GP-EE (mg/100 g
DW)
Compound Phenolic family λ (nm) Concentration (mg/100 g)
Gallic acid Phenolic acid 280 9.43±0.42
Caffeic acid Phenolic acid 320 9.69±0.10
Caftaric acid Phenolic acid 320 16.32±0.13
Protocatechuic acid Phenolic acid 280 27.07±0.71
Catechin Flavanol 280 33.74±0.81
Epicatechin Flavanol 280 35.66±0.59
Procyanidin B1 Flavanol 280 21.62±0.43
Quercetin-3-O-rutinoside (rutin) Flavonol 370 20.53±0.43
Quercetin-3-O-glucoside Flavonol 370 50.92±0.04
Kaempferol-3-O-glucoside Flavonol 370 21.92±0.12
Quercetin 3-O-galactoside Flavonol 370 6.42±0.31
Kaempferol 3-O-galactoside Flavonol 370 10.05±0.31
Kaempferol 3-O-glucuronide Flavonol 370 5.82±0.18
Total phenols (mg/g) 765 12800.13±870
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Anti-inflammatory Activity of GP-EE on LPS-activated N13
Cells
The anti-inflammatory property was analysed by in vitro as-
says on N13 cells stimulated with LPS and then treated with
different concentrations of GP-EE. It is known that N13
microglia produces a repertoire of cytokines similar to primary
microglia [18] after stimulation with the classical pro-
inflammatory agent LPS. Accordingly, present results show
up-regulation of mRNA expression of pro-inflammatory mol-
ecules in N13 microglia at the time points studied (1, 4 and
6 h) after LPS-stimulation. Molecules tested were the cyto-
kines TNF-α, IL-1 β; the inflammatory enzyme iNOS; the
receptor TLR-4 as well as the molecule iba-1. Specifically,
mRNA values reached a maximum at hour 1 for TNF-α and
TLR-4; hour 4 for IL-1 β, and at hour 6 for iNOS and Iba-1.
To assay whether GP-EE exerts any protective effect on LPS-
stimulated cells, N13 cells were simultaneously treated with
LPS and different concentrations of GP-EE (0, 1, 5 and 10 μg/
mL on polyphenols). No cytotoxicity was observed for GP-
EE treatments at the tested concentrations (data not shown), as
tested by cell viability assay. Similarly, GP-EE did not up-
regulate the mRNA expression of pro-inflammatory factors
when it was added to control cells not stimulated with LPS
(data not shown).
Interestingly, GP-EE decreased the up-regulation of the
mRNA of all the pro-inflammatory factors studied (TNF-α,
TLR-4, IL-1 β, iba-1 and iNOS,) after LPS- stimulation in a
dose-dependent manner (Fig. 2). In the presence of GP-EE the
expression of TNF-α mRNAwas strongly inhibited, showing
a significant decrease (50 % with respect to LPS-treated cells)
with a medium concentration of GP-EE (5 μg/mL on
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Fig. 2 The protective effect of
GP-EE on the expression of
mRNA of: TNF- α (a), TLR-4
(b), IL-1 β (c), Iba-1 (d) and
iNOS (e) in N13 microglia cells.
N13 cells activated with LPS
(1 μg/mL) were treated with
different concentrations of GP-
EE. All data are presented as
mean±S.D of three independent
experiments. Bonferroni analysis
was employed to compared the
differences between the
experimental groups: * p<0.05,
** p<0.01 and ***p<0.001
compared with control with LPS
alone; # p<0.05 compared with
1 μg/ml GP-EE and
&&&p<0.001 compared with
5 μg/ml GP-EE
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polyphenols) and an even higher decrease (90 % with respect
to LPS-stimulated cells; p<0.05; Fig. 2a) using the highest
concentration of GP-EE tested (10 μg/mL on polyphenols).
TLR-4 is the central component of the LPS receptor [26].
Our results show that TLR-4 mRNA also increased after LPS-
stimulation. Simultaneous treatment with the highest concen-
tration of GP-EE (10 μg/mL) significantly decreased TLR-4
mRNA to a value of 40.63 % with respect to LPS-treated cells
(p<0.05; Fig. 2b), thus also interfering in the expression of the
LPS-receptor.
The expression of IL- β mRNA was also significantly
inhibited in presence of GP-EE and the decrease was also
dose-dependent. There was a decrease of up to 42 % with
respect to LPS cells stimulated with the highest concentration
of GP-EE (10 μg/mL on polyphenols; p<0.001; Fig. 2c).
Iba-1 is a microglia/macrophage-specific calcium-binding
protein that participates in membrane ruffling and phagocyto-
sis in activated microglia [27]. Accordingly, the activation of
Iba-1 mRNA expression was observed after LPS-stimulation
(Fig. 2d). Iba-1 mRNA values also decreased with GP-EE
with respect to LPS-treated cells, being statistically significant
at concentrations corresponding to 5 μg/mL and 10 μg/mL of
polyphenols (75 and 38 % with respect to LPS-stimulated
cells; p<0.05).
Finally, we tested the pro-inflammatory enzyme iNOS. GP-
EE also decreases the upregulation of iNOS mRNA after the
LPS-stimulation of N13, but the effect was less pronounced
than that described above, reaching values of up to 84.6 %
(p<0.05) and 72 % (p<0.001) with regard to that of LPS-
stimulated culture (Fig. 2e) at GP-EE concentrations of 5 and
10 μg/mL of polyphenols respectively. Interestingly, analysis
of protein isolated from LPS-stimulated N13 cells also con-
firmed a decrease in iNOS protein expressions on LPS-
stimulation when compared with cells treated with GP-EE.
Our results (Fig. 3) show an approximately 40 % inhibition of
iNOS protein by GP-EE at doses of 5 and 10 μg/mL poly-
phenols (p<0.05).
In conclusion, GP-EE exerts a clear anti-inflammatory
effect in vitro, decreasing all of the pro-inflammatory factors
that characterize microglial activation. These results coincide
or agree with those of other research groups. Indeed, a similar
finding has recently been reported and thus nature molecules
such as flavonoids and tocopherols inhibit the release of pro-
inflammatory cytokines after activating microglia with LPS
[11–13].
Catechin is one of the most abundant flavanols in GP-EE. It
has been reported that catechin isolated from Juniperus rigida
effectively inhibits LPS-induced NO production in
RAW264.7 macrophage cells [28]. We can, therefore, suggest
that the anti-inflammatory properties of GP-EE make it an
ideal source of ingredients to be used as a preventive for
neurodegenerative processes. In this regard, wine consump-
tion has been reported as potentially protecting against certain
neurological disorders and that its neuroprotective activity is
related to its polyphenolic content [29]. However, wemust not
overlook the fact that other components of GP-EE may also
contribute to its anti-inflammatory properties. In fact, the
second main component in GP-EE is protein (14 %), mainly
in the form of peptides and free amino acids and it is known
that vegetable peptides, such as the lunasin from soybean,
exert anti-oxidant and anti-inflammatory properties [30].
Neuroinflammation is an important contributor to the path-
ogenesis of neurodegenerative disorders such as Alzheimer’s
or Parkinson’s disease, both of which present an increasing
health problem in modern society [7–10]. One of the hall-
marks of neurodegeneration is the presence of activated mi-
croglia, the resident macrophages in the central nervous sys-
tem, and the first line of defense after tissue damage and/or
infection. However, activated microglia may also contribute to
neurodegeneration through the release of pro-inflammatory
and/or cytotoxic factors such as IL −1 β, TNF-α, NO and
reactive oxygen intermediates among others. Therefore, after
an initial insult microglia activation damages neurons that
then release toxic soluble factors. These in turn induce
microglial activation, termed as reactive microgliosis. Thus,
a self-perpetuating cycle causing prolonged inflammation is
created [7, 8]. In this context it has been proposed that regu-
lating excessive microglial activation may be therapeutic in
Fig. 3 Inhibitory effect of GP-EE on the expression of the iNOS protein
in LPS-stimulated N13 cells. Bands were scanned and the relative density
of iNOS (iNOS/ β -actin) was calculated (a). Results are mean±SD of
three different experiments. T-student analysis was employed (p<0.05 vs
control). The lower panel shows a representative immunoblot in which
iNOS is detected (b)
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neurodegenerative diseases [31]. Therefore, we can suggest
that the anti-inflammatory properties of GP-EE make it an
ideal source of ingredients to be used as chemopreventive
agents in neurodegenerative disorders linked to neuroinflam-
mation such as Alzheimer’s or Parkinson’s disease— a grow-
ing health concern in modern societies [7–10].
The potential use of polyphenols for the prevention/
treatment of neurological disorders is largely hindered
by their complexity and also by the limited knowledge
regarding their bioavailability, metabolism, and bioac-
tivity, especially in the brain. However, Wang et al. [32]
have recently demonstrated that after dietary supple-
mentation with polyphenolic preparations from grape,
bioactive polyphenol metabolites selectively reach and
accumulate in the brain. In a mouse model of
Alzheimer’s disease, these polyphenolic preparations
significantly mitigate amyloid-(Aβ) mediated neuropa-
thology and cognitive impairments.
In conclusion, we have developed a biological extraction
process that allows grape pomace to be extracted with several
advantages such as high stability and high content of bioactive
compounds such as polyphenols and peptides, while avoiding
the use of of xenobiotics or toxic reagents. The results strongly
support that this extract possesses anti-inflammatory proper-
ties that have been widely linked to polyphenols. As a result,
GP-EE may be of therapeutic interest in neurodegenerative
diseases linked to neuroinflammation by acting as a chemo-
preventive agent. Thus, we propose the use of GP-EE as a
natural extract whose implementation in the functional food
field could provide health benefits.
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